Cargando…

Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal doxorubicin for brain drug delivery with a post-insertion approach

OBJECTIVE(S): Brain cancer treatments have mainly failed due to their inability to cross the blood-brain barrier. Several studies have confirmed the presence of glutathione (GSH) receptors on BBB’s surface, as a result, products like 2B3-101, which contain over 5% pre-inserted GSH PEGylated liposoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehrabian, Amin, Vakili-Ghartavol, Roghayyeh, Mashreghi, Mohammad, Shokooh Saremi, Sara, Badiee, Ali, Arabi, Leila, Alavizadeh, Seyedeh Hoda, Moosavian, Seyedeh Alia, Jaafari, Mahmoud Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mashhad University of Medical Sciences 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148397/ https://www.ncbi.nlm.nih.gov/pubmed/35656188 http://dx.doi.org/10.22038/IJBMS.2022.60306.13369

Ejemplares similares

The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice
por: Mehrabian, Amin, et al.
Publicado: (2023)

Nanocarriers Call the Last Shot in the Treatment of Brain Cancers
por: Mehrabian, Amin, et al.
Publicado: (2022)

Redox-sensitive doxorubicin liposome: a formulation approach for targeted tumor therapy
por: Mirhadi, Elaheh, et al.
Publicado: (2022)

The role of size in PEGylated liposomal doxorubicin biodistribution and anti‐tumour activity
por: Dadpour, Saba, et al.
Publicado: (2022)

Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy
por: Askarizadeh, Anis, et al.
Publicado: (2023)

Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
por: Mashreghi, Mohammad, et al.
Publicado: (2020)

Anti-tumor activity of silymarin nanoliposomes in combination with iron: In vitro and in vivo study
por: Doagooyan, Maham, et al.
Publicado: (2023)

Development of RNA aptamers as molecular probes for HER2(+) breast cancer study using cell-SELEX
por: Moosavian, Seyedeh Alia, et al.
Publicado: (2015)

The role of nanoliposome bilayer composition containing soluble leishmania antigen on maturation and activation of dendritic cells
por: Saremi, Sara Shokooh, et al.
Publicado: (2018)

Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy
por: Vakili-Ghartavol, Roghayyeh, et al.
Publicado: (2020)

Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids
por: Hatamipour, Mahdi, et al.
Publicado: (2019)

Sphingomyelin liposome bearing whole Leishmania lysate antigens induce strong Th2 immune response in BALB/c mice
por: Biari, Nazanin, et al.
Publicado: (2021)

Anti-tumor effects of PEGylated-nanoliposomes containing ginger extract in colorectal cancer-bearing mice
por: Yavari, Maryam, et al.
Publicado: (2022)

Association between Exudative Age-related Macular Degeneration and the G6721T Polymorphism of XRCC7 in Outdoor Subjects
por: Saadat, Iraj, et al.
Publicado: (2012)

Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2023)

PEGylated-nanoliposomal clusterin for amyloidogenic light chain-induced endothelial dysfunction
por: Guzman-Villanueva, Diana, et al.
Publicado: (2017)

Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
por: Haghiralsadat, Fateme, et al.
Publicado: (2018)

Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles In Vivo
por: Kozics, Katarina, et al.
Publicado: (2021)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
por: Moosavian, Seyedeh Alia, et al.
Publicado: (2021)

Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma
por: Zahedipour, Fatemeh, et al.
Publicado: (2023)

Evaluation of the Biodistribution of Arginine, glycine, aspartic acid peptide-modified Nanoliposomes Containing Curcumin in Rats
por: Salehi Najafabadi, Parisa, et al.
Publicado: (2022)

The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles
por: Gao, Hongjun, et al.
Publicado: (2013)

Pharmacokinetics and Biodistribution of Pegylated Methotrexate after IV Administration to Mice
por: Yousefi, Gholamhossein, et al.
Publicado: (2018)

Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis
por: Salave, Sagar, et al.
Publicado: (2023)

Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study
por: Salem, Heba F, et al.
Publicado: (2015)

Changes in dietary habits and weight status during the COVID-19 pandemic and its association with socioeconomic status among Iranians adults
por: Maharat, Maryam, et al.
Publicado: (2023)

Biodistribution and toxicity of pegylated single wall carbon nanotubes in pregnant mice
por: Campagnolo, Luisa, et al.
Publicado: (2013)

Pegylated liposomal doxorubicin in ovarian cancer
por: Green, Andrew E, et al.
Publicado: (2006)

Pegylated liposomal doxorubicin in ovarian cancer
por: Strother, Robert, et al.
Publicado: (2009)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
por: Nik, Maryam Ebrahimi, et al.
Publicado: (2019)

Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
por: Gaillard, Pieter J., et al.
Publicado: (2014)

Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID‐19
por: Alavizadeh, Seyedeh Hoda, et al.
Publicado: (2022)

Pegylated liposomal doxorubicin in the management of ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2010)

A tale of the two PEGylated liposomal doxorubicins
por: Chou, Hunghsueh, et al.
Publicado: (2015)

Preparation, Characterization and Evaluation of Sun Protective and Moisturizing Effects of Nanoliposomes Containing Safranal
por: Golmohammadzadeh, Shiva, et al.
Publicado: (2011)

Harnessing aptamers against COVID-19: A therapeutic strategy
por: Mahmoudi, Ali, et al.
Publicado: (2023)

The Impact of PEGylation on Cellular Uptake and In Vivo Biodistribution of Gold Nanoparticle MRI Contrast Agents
por: El-Baz, Nagwa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n8jfermoqqt03g7botctgskbe2